Simcere Pharmaceutical (China)

562 papers and 5.9k indexed citations

About

In recent decades, authors affiliated with Simcere Pharmaceutical (China) have published 562 papers, which have received a total of 5.9k indexed citations. Scholars at this organization have produced 233 papers in Molecular Biology, 179 papers in Oncology and 136 papers in Pulmonary and Respiratory Medicine on the topics of Lung Cancer Treatments and Mutations (63 papers), Cancer Genomics and Diagnostics (59 papers) and Cancer Immunotherapy and Biomarkers (58 papers). Their work is cited by papers focused on Molecular Biology (2.7k citations), Oncology (1.2k citations) and Cancer Research (823 citations). Authors at Simcere Pharmaceutical (China) collaborate with scholars in China, United States and United Kingdom and have published in prestigious journals including Proceedings of the National Academy of Sciences, Nucleic Acids Research and Advanced Materials. Some of Simcere Pharmaceutical (China)'s most productive authors include Wen Wang, Xiaojin Yin, Feng Tang, Dake Li, Wei Huang, Minhang Xin, Aijun Lu, Jianping Zhou, Gaoyong Liao and Yin Ji.

In The Last Decade

Simcere Pharmaceutical (China)

496 papers receiving 5.8k citations

Countries citing scholars working at Simcere Pharmaceutical (China)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Simcere Pharmaceutical (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Simcere Pharmaceutical (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simcere Pharmaceutical (China) more than expected).

Fields of papers published by authors at Simcere Pharmaceutical (China)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Simcere Pharmaceutical (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Simcere Pharmaceutical (China) at the time of their publication.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026